PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
D. Ross Camidge, MD, PhD - Mastering MET and cMET and Recognizing Their Role in Advanced NSCLC
Visit https://www.peervoice.com/SEY860 to view the entire programme with slides. After completing “D. Ross Camidge, MD, PhD - Mastering MET and cMET and Recognizing Their Role in Advanced NSCLC”, participants will be able to: Differentiate between the mechanisms of MET-related activity with NSCLC and the evidence of MET as a primary therapeutic vulnerability for NSCLC; Recognize the role of MET-related activity in the development of acquired resistance to targeted therapies in patients with oncogene-positive NSCLC and the evidence of MET as a secondary therapeutic vulnerability for NSCLC; and Apply best practices to overcome challenges in the identification and management of patients with the full range of MET vulnerabilities in patients with NSCLC.